An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma.

Yu, Qingxin; Zhang, Facai; Feng, Dechao; Li, Dengxiong; Xia, Yuhui; Gan, Mei-Fu

Yu, Qingxin; Zhang, Facai; Feng, Dechao; Li, Dengxiong; Xia, Yuhui; Gan, Mei-Fu.

Afiliación

Yu Q; Department of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, China.
Zhang F; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Feng D; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Li D; Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
Xia Y; Department of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, China.
Gan MF; Department of Pathology, Taizhou Hospital, Wenzhou Medical University, Linhai, China.

Front Genet ; 13: 866696, 2022.

Article en En | MEDLINE | ID: mdl-36035192

Palabras clave

immune checkpoint; immune infiltration; inflammation; renal clear cell carcinoma; signature

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google